Janet H. Ransom

2.6k citations

44 papers · 1.7k indexed · h-index 18

Biochemistry top 5%
Immunology top 5%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 4
Critical Care and Intensive Care Medicine top 5%
Oncology top 10%
- Cancer Immunotherapy and Biomarkers 6
Management of Technology and Innovation top 5%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 7
Public Health, Environmental and Occupational Health
- Research on Leishmaniasis Studies 6
Organic Chemistry
- Synthesis and Biological Evaluation 4
Epidemiology
- Trypanosoma species research and implications 4
Molecular Biology
- Glycosylation and Glycoproteins Research 3

Co-authors: Lois McNay Michael G. Hanna Charles H. Evans Elisabeth Bloemena Chris J.L.M. Meijer Rik J. Scheper Jan B. Vermorken Helen Gall
Cited by: Biochemistry Immunology Critical Care and Intensive Care Medicine
Journals: International Journal of Cancer (5 papers)PLoS neglected tropical diseases (4 papers)Travel Medicine and Infectious Disease (2 papers)
Partner nations: United States Peru Netherlands

In The Last Decade

Janet H. Ransom

41 papers receiving 1.6k citations

Peers

Countries citing papers authored by Janet H. Ransom

Since Specialization

Citations

This map shows the geographic impact of Janet H. Ransom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet H. Ransom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet H. Ransom more than expected).

Fields of papers citing papers by Janet H. Ransom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet H. Ransom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet H. Ransom. The network helps show where Janet H. Ransom may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Janet H. Ransom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janet H. Ransom Line = papers co-authored together Janet H. Ransom links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial Alcohol and Alcoholism ·Stephanie S. O’Malley,Robert Miranda,Sarah W. Book,Thomas H. Chun,Thomas Liss,Robert Malcolm,Srinivas B. Muvvala,Hayley Treloar Padovano,Joseph P. Schacht,Brent Blackburn,Ivan Diamond,Janet H. Ransom,Megan L. Ryan,Daniel E. Falk,Raye Z. Litten	2025	2
2	Effects of a novel GABA‐B positive allosteric modulator, ASP8062, on alcohol cue‐elicited craving and naturalistic alcohol consumption in a multisite randomized, double‐blind, placebo‐controlled trial Alcohol Clinical and Experimental Research ·Joseph P. Schacht,Lara A. Ray,Robert Miranda,Daniel E. Falk,Megan L. Ryan,Joseph T. Sakai,Karen Miotto,Thomas H. Chun,Charles Scott,Janet H. Ransom,R. A. Krektuleva,朴正晃,Raye Z. Litten	2024	2
3	Evaluation of a diagnostic device, CL Detect rapid test for the diagnosis of new world cutaneous leishmaniasis in Peru PLoS neglected tropical diseases ·Max Grögl,Cui Debin,X.M. Zhang,Chloe Stanton,Rishabh Shrivastava,N. Winterhalter-Stocker,Nadine Kuiper,Aubie Nanninga,Janet H. Ransom,Ana Pilar Ramos,(unknown)	2023	6
4	Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers PLoS neglected tropical diseases ·Oussama Mouri,Cléa Melenotte,Romain Guéry,D.S. Sule,Cameron Barrs,A. Pérignon,Marc Théllier,E. Bourrat,Florentia Kaguelidou,M.Kep,Denis Malvy,Jean‐Pierre Gangneux,Alexandre Duvignaud,Christophe Ravel,Salvatore Cisternino,Janet H. Ransom,Éric Caumes,Olivier Lortholary,Max Grögl,Pierre Buffet	2023	0
5	Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial Travel Medicine and Infectious Disease ·Mahmoud Ahmed Ramadan,І. М. Радчук,Víctor H. González,Janet H. Ransom,Charles Scott,Geoffrey S. Dow,Mark Reid,Bryan Smith,Victor E. Zottig,Lisa Read,Yaling Li,Fred K. Chen	2021	7
6	Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis Travel Medicine and Infectious Disease ·Mahmoud Ahmed Ramadan,Janet H. Ransom,Geoffrey S. Dow,Bryan Smith,Lisa Read,Stephen Toovey	2017	20
7	A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence Neuropsychopharmacology ·Megan L. Ryan,Daniel E. Falk,Joanne B. Fertig,Beatrice Rendenbach‐Mueller,David A. Katz,Katherine Tracy,Eric C. Strain,Kelly E. Dunn,Kyle M. Kampman,Elizabeth M. Mahoney,Domenic A. Ciraulo,蒋咏秋,Nassima Ait‐Daoud,Bankole A. Johnson,Janet H. Ransom,Charles Scott,George F. Koob,Raye Z. Litten	2016	56
8	Treatment of Bleeding in Severely Thrombocytopenic Patients with Transfusion of Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP) Is Safe - Report of a Phase 1 Dose Escalation Safety Trial Blood ·Sherrill J. Slichter,Larry J. Dumont,José A. Cancelas,Terry Gernsheimer,Zbigniew M. Szczepiorkowski,Nancy M. Dunbar,Helle Skou Thomsen,Backseung Young,Neeta Rugg,Anat Kainan,Reinoud J.P. Bothof,Victor W. Macdonald,Raffaella Lecci,Janet H. Ransom	2016	4
9	Parasite Load Decrease during Application of a Safe and Easily Applied Antileishmanial Aminoglycoside Cream PLoS neglected tropical diseases ·Afif Ben Salah,Amor Zâatour,E. M. Shirokova,Di Jiang,Philip L. Smith,Karen M. Kopydlowski,Mara Kreishman-Deitrick,Carl J. Nielsen,Mahmoud Ahmed Ramadan,Janet H. Ransom,Gloria Morizot,Max Grögl,Pierre Buffet	2014	11
10	A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence Journal of Addiction Medicine ·Raye Z. Litten,Megan L. Ryan,Joanne B. Fertig,Daniel E. Falk,Bankole A. Johnson,Kelly E. Dunn,Alan I. Green,Helen M. Pettinati,Domenic A. Ciraulo,Ofra Sarid‐Segal,Kyle M. Kampman,Mary F. Brunette,Eric C. Strain,Nassima Ait‐Daoud Tiouririne,Janet H. Ransom,Charles Scott,Robert L. Stout	2013	216
11	A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide–frozen autologous platelets in healthy volunteers Transfusion ·Larry J. Dumont,José A. Cancelas,S. Hurst,Alan Siegel,Zbigniew M. Szczepiorkowski,Neeta Rugg,Amanda Martins Reis,Mahmoud Muhammad Atta Hussein,J. Giguere,Susan Dunn,Margaret A. O’Leary,Janet H. Ransom,竜一松本,Victor W. Macdonald	2012	64
12	A Double‐Blind, Placebo‐Controlled Trial Assessing the Efficacy of Levetiracetam Extended‐Release in Very Heavy Drinking Alcohol‐Dependent Patients Alcoholism Clinical and Experimental Research ·Joanne B. Fertig,Megan L. Ryan,Daniel E. Falk,Raye Z. Litten,Margaret E. Mattson,Janet H. Ransom,A.J. Van Mason,Charles Scott,Domenic A. Ciraulo,Alan I. Green,Nassima Ait‐Daoud Tiouririne,Bankole A. Johnson,Helen M. Pettinati,Eric C. Strain,Eric Devine,Mary F. Brunette,Kyle M. Kampman,D. Andrew Tompkins,Robert L. Stout,(unknown)	2012	43
13	Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers Vaccine ·As. Ali Livari,Melinda M. Rathkopf,Iain S. Sim,Tia Humaira Zahrah,Robert J. Hopkins,Lallan Giri,Gerakopoulos V,Janet H. Ransom,James A. Quinn,Gary S. Nabors,Carl J. Nielsen	2011	76
14	Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial The Lancet ·Jan B. Vermorken,A.M.E. Claessen,Harm van Tinteren,Helen Gall,Gabriela L. Ferrel,Sybren L. Meijer,Rik J. Scheper,Chris J.L.M. Meijer,Elisabeth Bloemena,Janet H. Ransom,Michael G. Hanna,Herbert M. Pinedo	1999	379
15	Lipoprotein(a) Serum Concentration and Apolipoprotein(a) Phenotype Correlate With Severity and Presence of Ischemic Cerebrovascular Disease Stroke ·Günther Jürgens,Wendy C. Taddei‐Peters,P Költringer,W. Petek,Qi Chen,Joachim Greilberger,Michael Hardegree-Ullman,Bryan T. Butman,Andrew G. Stead,Janet H. Ransom	1995	101
16	Identification of colon‐tumor‐associated antigens by T‐cell lines derived from tumor‐infiltrating lymphocytes and peripheral‐blood lymphocytes from patients immunized with an autologous tumor‐cell/bacillus calmette‐Guérin vaccine International Journal of Cancer ·Janet H. Ransom,刘玉龙 LIU Yulong,S. Dhanabagiyam,Doo Young Kwon,Michael G. Hanna,Nicholas Pomato	1993	14
17	Active Specific Immunotherapy of Human Colorectal Carcinoma with an Autologous Tumor Cell/Bacillus Calmette‐Guérin Vaccine Annals of the New York Academy of Sciences ·Michael G. Hanna,Janet H. Ransom,Nicholas Pomato,Leona C. Peters,Elisabeth Bloemena,Jan B. Vermorken,Herbert Hoover	1993	7
18	Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay Clinical Chemistry ·Wendy C. Taddei‐Peters,Bryan T. Butman,G. R. N. Jones,Mamoru Nishiyama,Michael Hardegree-Ullman,Janet H. Ransom	1993	46
19	Leukoregulin inhibits the growth of human glioblastoma in vitro Journal of Neuroimmunology ·Randall E. Merchant,Janet H. Ransom,Harold F. Young	1986	3
20	Endothelial cell growth supplement: a cell cloning factor that promotes the growth of monoclonal antibody producing hybridoma cells Journal of Immunological Methods ·C. Pintus,Janet H. Ransom,Charles H. Evans	1983	35

About Janet H. Ransom

Janet H. Ransom is a scholar working on Immunology, Critical Care and Intensive Care Medicine and Biochemistry, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Research on Leishmaniasis Studies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Synthesis and Biological Evaluation (4 papers), Trypanosoma species research and implications (4 papers), Immune Cell Function and Interaction (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Biochemistry (151 citations), Immunology (518 citations) and Critical Care and Intensive Care Medicine (89 citations). Janet H. Ransom has collaborated with scholars based in United States, Peru and Netherlands. Frequent co-authors include Lois McNay, Michael G. Hanna, Charles H. Evans, Elisabeth Bloemena, Chris J.L.M. Meijer, Rik J. Scheper, Jan B. Vermorken, Helen Gall, Herbert M. Pinedo and Sybren L. Meijer. Their work appears in journals such as International Journal of Cancer, PLoS neglected tropical diseases, Travel Medicine and Infectious Disease, Transfusion and Cellular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact